Model
Edge
4D Molecular Therapeutics
0001735084
Filing Type
4
Filing Date
6/19/2025
Updated
6/20/25, 2:04 PM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership